Michel Vanhaeverbeek

3.2k total citations
101 papers, 2.3k citations indexed

About

Michel Vanhaeverbeek is a scholar working on Immunology, Physiology and Epidemiology. According to data from OpenAlex, Michel Vanhaeverbeek has authored 101 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 24 papers in Physiology and 20 papers in Epidemiology. Recurrent topics in Michel Vanhaeverbeek's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (19 papers), Nitric Oxide and Endothelin Effects (12 papers) and Adipokines, Inflammation, and Metabolic Diseases (9 papers). Michel Vanhaeverbeek is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (19 papers), Nitric Oxide and Endothelin Effects (12 papers) and Adipokines, Inflammation, and Metabolic Diseases (9 papers). Michel Vanhaeverbeek collaborates with scholars based in Belgium, France and Austria. Michel Vanhaeverbeek's co-authors include Karim Zouaoui Boudjeltia, Pierre Van Antwerpen, Jean‐Louis Vincent, Michaël Piagnerelli, Dany Brohée, Karim Zouaoui Boudjeltia, Alexandre Fontaine Rousseau, Jean Nève, Jean Ducobu and Nicole Moguilevsky and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Michel Vanhaeverbeek

97 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michel Vanhaeverbeek Belgium	28	633	468	367	337	242	101	2.3k
Karim Zouaoui Boudjeltia Belgium	31	768 1.2×	510 1.1×	456 1.2×	322 1.0×	278 1.1×	97	2.5k
Hongwei Zhang China	29	704 1.1×	329 0.7×	337 0.9×	164 0.5×	230 1.0×	138	3.2k
Harald Schennach Austria	33	518 0.8×	293 0.6×	610 1.7×	295 0.9×	195 0.8×	136	3.3k
Nicole Moguilevsky Belgium	31	1.2k 1.9×	642 1.4×	855 2.3×	338 1.0×	141 0.6×	87	2.8k
Alan J. Husband Australia	29	859 1.4×	161 0.3×	542 1.5×	187 0.6×	101 0.4×	85	2.6k
Michael A. Silverman United States	28	860 1.4×	340 0.7×	780 2.1×	200 0.6×	109 0.5×	80	2.7k
Takashi Kaneko Japan	32	1.3k 2.0×	298 0.6×	912 2.5×	351 1.0×	104 0.4×	117	3.7k
Sandeep Gupta United States	31	338 0.5×	567 1.2×	761 2.1×	512 1.5×	121 0.5×	98	3.4k
Markus Schneemann Switzerland	25	658 1.0×	580 1.2×	868 2.4×	352 1.0×	139 0.6×	57	3.0k
Jiawei Wang China	30	820 1.3×	150 0.3×	1.9k 5.1×	321 1.0×	276 1.1×	160	3.9k

Countries citing papers authored by Michel Vanhaeverbeek

Since Specialization

Citations

This map shows the geographic impact of Michel Vanhaeverbeek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Vanhaeverbeek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Vanhaeverbeek more than expected).

Fields of papers citing papers by Michel Vanhaeverbeek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Vanhaeverbeek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Vanhaeverbeek. The network helps show where Michel Vanhaeverbeek may publish in the future.

Co-authorship network of co-authors of Michel Vanhaeverbeek

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Vanhaeverbeek. A scholar is included among the top collaborators of Michel Vanhaeverbeek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Vanhaeverbeek. Michel Vanhaeverbeek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roumeguère, Thierry, Caroline Noyon, Pierre Van Antwerpen, et al.. (2023). Role of Myeloperoxidase in ROS Generation and Inflammation Response on Prostate Epithelial Cells. Inflammation. 46(5). 1859–1870. 5 indexed citations

Becker, Benjamin De, et al.. (2016). Complications non-chirurgicales de la chirurgie bariatrique : à propos de quatre cas et revue de la littérature. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 37. 26–34. 1 indexed citations

Lelubre, Christophe, et al.. (2015). Ezetimibe plus a Statin after Acute Coronary Syndromes.. New England Journal of Medicine. 373(15). 1475–1476. 2 indexed citations

Soubhye, Jalal, Michel Vanhaeverbeek, Alexandre Fontaine Rousseau, et al.. (2014). Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae). Journal of Ethnopharmacology. 154(2). 361–369. 63 indexed citations

Soubhye, Jalal, Martine Prévost, Betina Elfving, et al.. (2014). Hybrid molecules inhibiting myeloperoxidase activity and serotonin reuptake: a possible new approach of major depressive disorders with inflammatory syndrome. Journal of Pharmacy and Pharmacology. 66(8). 1122–1132. 17 indexed citations

Simon, Philippe, et al.. (2013). Variable Stromal Periductular Expression of CD34 and Smooth Muscle Actin (SMA) in Intraductal Carcinoma of the Breast. PLoS ONE. 8(3). e57773–e57773. 25 indexed citations

Boudjeltia, Karim Zouaoui, Cédric Delporte, Pierre Van Antwerpen, et al.. (2013). Myeloperoxidase-Dependent LDL Modifications in Bloodstream Are Mainly Predicted by Angiotensin II, Adiponectin, and Myeloperoxidase Activity: A Cross-Sectional Study in Men. Mediators of Inflammation. 2013. 1–4. 14 indexed citations

Boudjeltia, Karim Zouaoui, Pierre Van Antwerpen, Nicole Moguilevsky, et al.. (2012). Exposure of Endothelial Cells to Physiological Levels of Myeloperoxidase-Modified LDL Delays Pericellular Fibrinolysis. PLoS ONE. 7(6). e38810–e38810. 18 indexed citations

Boudjeltia, Karim Zouaoui, Brice Faraut, Maria José Esposito, et al.. (2011). Temporal Dissociation between Myeloperoxidase (MPO)-Modified LDL and MPO Elevations during Chronic Sleep Restriction and Recovery in Healthy Young Men. PLoS ONE. 6(11). e28230–e28230. 27 indexed citations

10.

Beaufays, Jérôme, Laurence Fiévez, Yves Decrem, et al.. (2008). Ir-LBP, an Ixodes ricinus Tick Salivary LTB4-Binding Lipocalin, Interferes with Host Neutrophil Function. PLoS ONE. 3(12). e3987–e3987. 104 indexed citations

11.

Antwerpen, Pierre Van, Martine Prévost, Patrick Moreau, et al.. (2007). Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification. Bioorganic & Medicinal Chemistry. 16(4). 1702–1720. 21 indexed citations

12.

Kerkhofs, Myriam, Karim Zouaoui Boudjeltia, Patricia Stenuit, et al.. (2006). Sleep restriction increases blood neutrophils, total cholesterol and low density lipoprotein cholesterol in postmenopausal women: A preliminary study. Maturitas. 56(2). 212–215. 60 indexed citations

13.

Boudjeltia, Karim Zouaoui, Michel Guillaume, P. Delrée, et al.. (2006). Fibrinolysis and cardiovascular risk factors: Association with fibrinogen, lipids, and monocyte count. European Journal of Internal Medicine. 17(2). 102–108. 13 indexed citations

14.

Boudjeltia, Karim Zouaoui, Michaël Piagnerelli, Dany Brohée, et al.. (2004). Relationship between CRP and hypofibrinolysis: Is this a possible mechanism to explain the association between CRP and outcome in critically ill patients?. Thrombosis Journal. 2(1). 7–7. 18 indexed citations

15.

Vanhaeverbeek, Michel, et al.. (2004). [Tuberculous sacroiliitis: report of a case].. PubMed. 25(2). 99–102. 3 indexed citations

16.

Piagnerelli, Michaël, et al.. (2003). Modifications of Red Blood Cell Shape and Glycoproteins Membrane Content in Septic Patients. Advances in experimental medicine and biology. 510. 109–114. 13 indexed citations

17.

Vanhaeverbeek, Michel, et al.. (1993). Comparison of the efficacy and safety of amikacin once or twice-a-day in the treatment of severe gram-negative infections in the elderly.. PubMed. 31(3). 153–6. 18 indexed citations

18.

Brohée, Dany, Pierre Nève, Michel Vanhaeverbeek, & André Lefèvre. (1991). Is lymphopenia an obligatory side effect of all cancer chemotherapy treatments. Medical science research. 19(23). 801–802. 1 indexed citations

19.

Brohée, Dany, Michel Vanhaeverbeek, Bernard Kennès, & Pierre Nève. (1990). Multilinear regression analysis of the lymphocyte response to lectin mitogens as related to the subjects' age and the subsets of cultured peripheral blood mononuclear cells. Medical science research. 18(16). 639–641. 1 indexed citations

20.

Brohée, Dany, Michel Vanhaeverbeek, Bernard Kennès, & Pierre Nève. (1988). Monocyte contamination of Ficoll-diatrizoate density gradient isolated peripheral blood lymphocytes. Medical science research. 16. 823–824. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact